COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2022

Mar 3, 2022

SEC Form 4/A — Form 4/A

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2022-02-10

Reporting Person: Tupper Colleen (EVP & Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-10	Common Stock	A	52500	—	Acquired	94500	Direct
2022-02-10	Common Stock	A	4212	—	Acquired	98712	Direct
2022-02-10	Common Stock	F	2821	$17.63	Disposed	95891	Direct
2022-02-10	Common Stock	F	1237	$17.63	Disposed	94654	Direct

Footnotes

F1: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2023, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

F2: On February 10, 2022, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 4,212 performance share units granted in the issuer's prior fiscal year.

F3: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

F4: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.